New heart disease mechanism revealed: Next-generation targeted therapy shows benefit across mutation types

A study led by the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), working in collaboration with an ...
News-Medical.Net

New molecular mechanism identified in common inherited heart disease

A study led by the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), working in collaboration with an ...
EurekAlert!

MD Anderson EGFR Classification licensed by BostonGene and Tempus to provide new insight on atypical mutations in lung cancer

Companies will provide classification information on EGFR mutations in non-small cell lung cancer that may guide clinical decision-making In a retrospective analysis, the MD Anderson EGFR ...
ascopubs.org

Swiss-PO 2025: Advancing Cancer Mutation and Structural Analysis for Precision Oncology With the Latest Release

Impact of Germline BRCA Mutation Status on Antitumor Activity of Modified FOLFIRINOX in Patients With Advanced Pancreatic Cancer: An Exploratory Analysis Swiss-PO was expanded and redesigned to ...
The American Journal of Managed Care

INCA033989 Shows Potential as a Targeted Approach for Myelofibrosis With Mutant Calreticulin: Claire Harrison, MD

Harrison noted that responses were observed across calreticulin mutation types and among patients with additional mutations, with minimal toxicity reported to date. She concluded by describing ...

Researchers expand plasmonic liquid biopsy platform to early-stage colorectal cancer

A research team led by Minyoung Lee and Sunggyu Park of The Korea Institute of Materials Science (KIMS) Bio & Health ...
Healthline

KRAS Mutation in Lung Cancer: What You Should Know

Lung cancer is an aggressive type of cancer that begins in the lungs but may spread to other areas of the body. With an estimated 30% 5-year relative survival rate, lung cancer is among the deadliest ...